Cagrilintide is a long-acting amylin analogue investigated for appetite regulation, gastric emptying delay, body weight management, and metabolic research.
| Purity | >98% |
| Form | Lyophilized powder |
| Storage | -20°C |
Science-backed research overview for this compound
Cagrilintide is a long-acting, synthetic analogue of the natural hormone amylin. Amylin is co-secreted with insulin by the pancreas and plays a vital role in signaling satiety and fullness to the brain.
Cagrilintide acts as a non-selective agonist of the amylin receptors. It works by slowing down gastric emptying (the rate at which food leaves the stomach) and suppressing the secretion of glucagon. This leads to a prolonged feeling of fullness and better blood sugar regulation in research settings.
Research is currently investigating Cagrilintide in combination with GLP-1 agonists (like Semaglutide). Early data suggests that targeting both the amylin and GLP-1 pathways produces a synergistic effect on weight loss and metabolic health that far exceeds either peptide alone.